Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 3/20 | 0.59 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.59 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.52 |
| ▸ | MAOB | P27338 | 7/20 | 0.43 |
| ▸ | IDO1 | P14902 | 2/20 | 0.43 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.43 |
| ▸ | PPARG | P37231 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | MAOA | P21397 | 1/20 | 0.40 |
| ▸ | LTA4H | P09960 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2293337 | 0.84 | MAOB (0.45) | FFAR4FFAR1PARP10MAOBIDO1 | |
| SCHEMBL2293600 | 0.82 | FFAR4 (0.60) | FFAR4FFAR1PARP10MAOBIDO1 | |
| SCHEMBL2291091 | 0.81 | PARP10 (0.55) | FFAR4FFAR1PARP10MAOBIDO1 | |
| SCHEMBL2291846 | 0.80 | FFAR4 (0.45) | FFAR4FFAR1PARP10IDO1ALDH1A1 | |
| SCHEMBL2290205 | 0.80 | FFAR4 (0.50) | FFAR4FFAR1IDO1ALDH1A1 | |
| SCHEMBL2292282 | 0.79 | FFAR4 (0.65) | FFAR4FFAR1PARP10MAOBIDO1 | |
| SCHEMBL2290707 | 0.79 | IDO1 (0.41) | FFAR4FFAR1PARP10IDO1ALDH1A1 | |
| SCHEMBL2736160 | 0.78 | LTA4H (0.61) | FFAR4FFAR1MAOBPPARGSIGMAR1 | |
| SCHEMBL2291386 | 0.78 | PARP10 (0.59) | FFAR4FFAR1PARP10MAOBIDO1 | |
| SCHEMBL2290698 | 0.78 | MAOB (0.44) | FFAR4FFAR1MAOBSIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2149545-B1 | METHOD FOR PRODUCING BENZALDEHYDE COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2016-10-05 | — | — | EP | disclosed |
| CN-101679172-B | Method for producing benzaldehyde compound | SUMITOMO CO LTD | 2013-05-29 | — | — | CN | disclosed |
| US-7994367-B2 | Method for producing benzaldehyde compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-08-09 | — | — | US | disclosed |
| US-20100210879-A1 | METHOD FOR PRODUCING BENZALDEHYDE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-08-19 | — | — | US | disclosed |
| CN-101679172-A | Method for producing benzaldehyde compound | SUMITOMO CHEMICAL CO | 2010-03-24 | — | — | CN | disclosed |
| EP-2149545-A1 | METHOD FOR PRODUCING BENZALDEHYDE COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2010-02-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100210879-A1 | METHOD FOR PRODUCING BENZALDEHYDE COMPOUND | NQO1, C9, TRPA1 | FFAR4 3092/4885FFAR1 3643/4885PARP10 167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.